Although the lifetime risk of BC among those with BRCA1 mutations can be as high as 80%, individuals with mutations in BRCA1 or BRCA2 generally have a 55–65% or 45% increased risk of BC, respectively (National Cancer Institute, 2017). The gene discussed is BRCA1; the disease is breast cancer.